Briviact Tablet, Film Coated
Product Images NDC 50474-570

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Briviact (NDC 50474-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ucb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brivaracetam 01)

Chemical structure of brivaracetam, the active ingredient in Briviact. The diagram shows the molecular arrangement of atoms forming the compound.*

FDA Label Image

Figure 1 (Brivaracetam 02)

A bar graph depicting the proportion of patients (%) with various reductions in seizure frequency from baseline (%) comparing placebo and Briviact 50 mg/day, 100 mg/day, and 200 mg/day doses. The categories of reduction are divided as worse, 0 to <25%, 25 to <50%, 50 to <75%, and 75 to 100%. Each category displays bars for placebo and the three Briviact dose groups with respective patient numbers indicated.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Carton)

Packaging label for Briviact (brivaracetam) 10 mg film-coated tablets. The label indicates the package contains 60 tablets and includes directions for pharmacists to dispense an accompanying medication guide. Manufactured for UCB, Inc., Smyrna, GA. The label features dosing and storage instructions, product name, strength, and barcode.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Carton)

The image shows the flat packaging label for Briviact tablets containing 25 mg of brivaracetam. It is a film-coated oral tablet manufactured by UCB, Inc. The label indicates a 60-tablet count and includes storage instructions and a barcode. The design features red and yellow colors with the proprietary and generic names prominently displayed.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Carton)

Packaging label for Briviact (brivaracetam) tablets 50 mg by UCB, Inc. The label includes branding and dosage strength prominently. It states each tablet contains 50 mg brivaracetam and instructs storage at 25°C with allowed excursions. The box holds 60 film-coated tablets, manufactured for UCB, Inc. in Belgium. A barcode and pharmacist dispensing notice directing to accompany medication guide are shown.*

FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Carton)

Box packaging label for Briviact (brivaracetam) tablets 75 mg by UCB, Inc. The label indicates the product is oral film-coated tablets containing 75 mg brivaracetam each. Packaging includes lot, NDC 50474-670-66, quantity of 60 tablets, storage instructions, and a barcode. The product is made in Belgium and manufactured by UCB, Inc., Smyrna, GA.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Carton)

Packaging label for Briviact (brivaracetam) tablets 100 mg. The film-coated oral tablet package contains 60 tablets and includes storage instructions. Manufactured for UCB, Inc., Smyrna, GA, made in Belgium. The label features a barcode, NDC 50474-770-66, and pharmacist dispensing guidance.*

FDA Label Image

Principal Display Panel (10 mg/mL Bottle Carton)

Packaging label for Briviact (brivaracetam) oral solution 10 mg/mL in a 300 mL bottle. The label includes drug name, strength, form, pharmacist dispensing instructions, storage and discard information, barcode, manufacturer details (UCB, Inc., Smyrna, GA, Made in Belgium), and regulatory markings. The design features a purple and white color scheme with highlighted areas for seals and supplier info.*

FDA Label Image

Principal Display Panel (50 mg/5 mL Vial Carton)

Packaging label for Briviact (brivaracetam) injection 50 mg/5 mL (10 mg/mL) by UCB, Inc. The label indicates it is for intravenous use only and contains 10 vials. The NDC number 50474-970-75 is displayed along with storage instructions and manufacturing details. The design includes a maroon color block and regulatory markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.